Literature DB >> 7835177

Orbicular synkinesis after facial paralysis: treatment with botulinum toxin.

P Roggenkämper1, R Laskawi, W Damenz, M Schröder, Z Nüssgens.   

Abstract

Involuntary lid closure not rarely accompanies aberrant regeneration of nerve fibers after different types of facial paralysis. 23 patients with such synkinesis were treated with botulinum toxin injections into the orbicularis oculi muscle. After periocular injections all patients showed much improvement: a period of, on the average, 13 symptom-free weeks was followed by a period of minimal symptoms. There were only minor complications. Whenever repeated treatment is necessary, botulinum toxin proves to be an effective therapy for involuntary lid closure after defective healing following facial paralysis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835177     DOI: 10.1007/bf01204598

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  3 in total

1.  [The autoparalytic syndrome--a leading symptom of postparetic facial function].

Authors:  E Stennert
Journal:  Arch Otorhinolaryngol       Date:  1982

2.  [Blepharospasm treatment with botulinum toxin (follow-up)].

Authors:  P Roggenkämper
Journal:  Klin Monbl Augenheilkd       Date:  1986-10       Impact factor: 0.700

3.  Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. American Academy of Ophthalmology.

Authors: 
Journal:  Ophthalmology       Date:  1989-09       Impact factor: 12.079

  3 in total
  5 in total

1.  [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin].

Authors:  J Winterhoff; R Laskawi
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

2.  Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database.

Authors:  Salma Ahsanuddin; Savannah Roy; Wissam Nasser; Roman Povolotskiy; Boris Paskhover
Journal:  Aesthetic Plast Surg       Date:  2020-10-30       Impact factor: 2.326

3.  A Novel Long-term Therapy of Facial Synkinesis with Botulinum Neurotoxins Type A and Fillers.

Authors:  Adam Wiener; Khasha Touloei; Bradley P Glick
Journal:  J Clin Aesthet Dermatol       Date:  2011-03

4.  Surgical and conservative methods for restoring impaired motor function - facial nerve, spinal accessory nerve, hypoglossal nerve (not including vagal nerve or swallowing).

Authors:  R Laskawi; S Rohrbach
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

Review 5.  The use of botulinum toxin in head and face medicine: an interdisciplinary field.

Authors:  Rainer Laskawi
Journal:  Head Face Med       Date:  2008-03-10       Impact factor: 2.151

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.